author-photo

Luca Mologni

University of Milano-Bicocca
University of Milan

109

Papers

4095

Citations

Citation Trend

Filter By

Papers (83) Sort By

Journal Conference Others

Dual Kinase Targeting in Leukemia

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
CD24/Siglec-10 "Don't Eat Me" Signal Blockade Is a Potential Immunotherapeutic Target in Mantle-Cell Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (1)
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (2)
Resistance mechanisms to ALK TKIs in tumors other than lung cancer

2021
- Luca Mologni
Show All
- Source
- Cite
- Save
Citations (0)
New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)-Positive Cancer

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Mutational landscape analysis in systematic anaplastic large cell lymphoma identifies novel prognostic markers.

2020
Show All
- Source
- Cite
- Save
Citations (0)
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (4)
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.

2020 Haematologica
Show All
- Source
- Cite
- Save
Citations (11)
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.

2020 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (6)